spacer
home > ict > spring 2018 > editor’s comment
PUBLICATIONS
International Clinical Trials

Editor’s Comment

Bill Clinton once said when commenting on elections “it is the economy, stupid.” When discussing clinical research, forgetting that “it is the patient, stupid” is easy. The patient must always be at the centre of considerations from initial research to commercialisation. This concept is explored by Justin Schroeder at PCI Pharma Services (EPC page 44). He reiterates a famous quote from the US Surgeon General that “drugs don’t work in people that don’t take them” and regrets that as few as 30-40% of patient prescriptions are taken in a compliant manner. One way to improve patient compliance is in the design of the trials that contribute towards the approval of drugs, bearing in mind the dictum “drugs are not approved as such, their labels are”, so the better the label, the better the patient compliance. Jeff Lee at Bracket expands on these thoughts, exploring how sponsors can strengthen their perception of patient centricity, thereby improving recruitment, retention, and protocol adherence within the trial (page 30).

The patient becoming more tech-savvy should, in principle, make the application of technology to trials easier, provided that sponsors can develop the necessary mechanisms. Some of these new tools are described by Aaron Fleishman and Sarah Mandracchia at BBK Worldwide, concentrating on the use of modern techniques for managing study timelines and budgets (page 18).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

spacer
Dr Graham Hughes
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Dizal Pharmaceutical, a biotechnology company, announce a strategic partnership. Under the terms of the collaboration, WuXi STA will become the preferred CDMO partner of Dizal Pharmaceutical for GMP production, providing integrated CMC (Chemical, manufacturing and Control) process research and manufacturing services from API to drug product.
More info >>

White Papers

Using Device Strategy to Drive R&D Productivity

Phillips-Medisize


More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement